nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC9A6—IgA glomerulonephritis	0.00781	0.00781	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC39A8—IgA glomerulonephritis	0.00781	0.00781	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC7A5—IgA glomerulonephritis	0.00745	0.00745	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC6A20—IgA glomerulonephritis	0.00745	0.00745	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—SLC39A8—IgA glomerulonephritis	0.00739	0.00739	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC38A2—IgA glomerulonephritis	0.00715	0.00715	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC30A5—IgA glomerulonephritis	0.00715	0.00715	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—SLC6A20—IgA glomerulonephritis	0.00705	0.00705	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC20A1—IgA glomerulonephritis	0.00694	0.00694	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—SLC38A2—IgA glomerulonephritis	0.00675	0.00675	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Monoamine Transport—AGT—IgA glomerulonephritis	0.00638	0.00638	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC20A1—IgA glomerulonephritis	0.00615	0.00615	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—RAB11FIP2—IgA glomerulonephritis	0.00588	0.00588	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Monoamine Transport—AGT—IgA glomerulonephritis	0.00566	0.00566	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—IgA glomerulonephritis	0.00565	0.00565	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—SLC1A3—IgA glomerulonephritis	0.00528	0.00528	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC39A8—IgA glomerulonephritis	0.00526	0.00526	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC9A6—IgA glomerulonephritis	0.00526	0.00526	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—SLC38A2—IgA glomerulonephritis	0.00525	0.00525	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC20A1—IgA glomerulonephritis	0.00524	0.00524	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (12/13) signalling events—GNG12—IgA glomerulonephritis	0.00519	0.00519	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC7A5—IgA glomerulonephritis	0.00502	0.00502	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A20—IgA glomerulonephritis	0.00502	0.00502	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—IgA glomerulonephritis	0.00501	0.00501	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Dopaminergic Neurogenesis—TGFB1—IgA glomerulonephritis	0.00485	0.00485	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC38A2—IgA glomerulonephritis	0.00481	0.00481	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC30A5—IgA glomerulonephritis	0.00481	0.00481	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC39A8—IgA glomerulonephritis	0.00466	0.00466	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC9A6—IgA glomerulonephritis	0.00466	0.00466	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—GNG12—IgA glomerulonephritis	0.00456	0.00456	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC7A5—IgA glomerulonephritis	0.00444	0.00444	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC6A20—IgA glomerulonephritis	0.00444	0.00444	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—RGS4—IgA glomerulonephritis	0.0043	0.0043	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC1A3—IgA glomerulonephritis	0.00428	0.00428	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC38A2—IgA glomerulonephritis	0.00426	0.00426	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC30A5—IgA glomerulonephritis	0.00426	0.00426	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—AMPK Signaling—CCNB1—IgA glomerulonephritis	0.0042	0.0042	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—YWHAH—IgA glomerulonephritis	0.00415	0.00415	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—SLC1A3—IgA glomerulonephritis	0.00405	0.00405	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—SLC38A2—IgA glomerulonephritis	0.00403	0.00403	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC39A8—IgA glomerulonephritis	0.00397	0.00397	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ATP6V1B2—IgA glomerulonephritis	0.00397	0.00397	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC9A6—IgA glomerulonephritis	0.00397	0.00397	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—RAB11FIP2—IgA glomerulonephritis	0.00395	0.00395	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—ATP2B1—IgA glomerulonephritis	0.00389	0.00389	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—NMU—IgA glomerulonephritis	0.00382	0.00382	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—CP—IgA glomerulonephritis	0.00382	0.00382	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A20—IgA glomerulonephritis	0.00379	0.00379	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC7A5—IgA glomerulonephritis	0.00379	0.00379	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC30A5—IgA glomerulonephritis	0.00363	0.00363	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC38A2—IgA glomerulonephritis	0.00363	0.00363	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—FPR3—IgA glomerulonephritis	0.00359	0.00359	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC20A1—IgA glomerulonephritis	0.00353	0.00353	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—RAB11FIP2—IgA glomerulonephritis	0.0035	0.0035	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—GNG12—IgA glomerulonephritis	0.00349	0.00349	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NMU—IgA glomerulonephritis	0.00341	0.00341	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—GPR65—IgA glomerulonephritis	0.0034	0.0034	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (12/13) signalling events—VAV3—IgA glomerulonephritis	0.00328	0.00328	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—SLC1A3—IgA glomerulonephritis	0.00315	0.00315	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC20A1—IgA glomerulonephritis	0.00312	0.00312	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—FPR3—IgA glomerulonephritis	0.00308	0.00308	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—IgA glomerulonephritis	0.00304	0.00304	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—GNG12—IgA glomerulonephritis	0.003	0.003	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—IgA glomerulonephritis	0.00289	0.00289	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—IgA glomerulonephritis	0.00288	0.00288	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PSAP—IgA glomerulonephritis	0.00288	0.00288	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADORA3—IgA glomerulonephritis	0.00272	0.00272	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—GNG12—IgA glomerulonephritis	0.00272	0.00272	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC39A8—IgA glomerulonephritis	0.00267	0.00267	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ATP6V1B2—IgA glomerulonephritis	0.00267	0.00267	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC9A6—IgA glomerulonephritis	0.00267	0.00267	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR65—IgA glomerulonephritis	0.00263	0.00263	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—CP—IgA glomerulonephritis	0.00257	0.00257	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC1A3—IgA glomerulonephritis	0.00255	0.00255	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A20—IgA glomerulonephritis	0.00255	0.00255	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC7A5—IgA glomerulonephritis	0.00255	0.00255	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NMU—IgA glomerulonephritis	0.00253	0.00253	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—GNG12—IgA glomerulonephritis	0.0025	0.0025	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC30A5—IgA glomerulonephritis	0.00244	0.00244	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC38A2—IgA glomerulonephritis	0.00244	0.00244	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ATP2B1—IgA glomerulonephritis	0.00244	0.00244	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—HMOX1—IgA glomerulonephritis	0.00242	0.00242	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—SLC1A3—IgA glomerulonephritis	0.00241	0.00241	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR1—IgA glomerulonephritis	0.00241	0.00241	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC9A6—IgA glomerulonephritis	0.00237	0.00237	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC39A8—IgA glomerulonephritis	0.00237	0.00237	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ATP6V1B2—IgA glomerulonephritis	0.00237	0.00237	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—FPR3—IgA glomerulonephritis	0.00234	0.00234	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—TBL1XR1—IgA glomerulonephritis	0.00234	0.00234	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADORA3—IgA glomerulonephritis	0.00233	0.00233	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—CP—IgA glomerulonephritis	0.00227	0.00227	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC6A20—IgA glomerulonephritis	0.00226	0.00226	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC7A5—IgA glomerulonephritis	0.00226	0.00226	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GPR65—IgA glomerulonephritis	0.00225	0.00225	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GNG12—IgA glomerulonephritis	0.00223	0.00223	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—PSAP—IgA glomerulonephritis	0.00219	0.00219	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC1A3—IgA glomerulonephritis	0.00218	0.00218	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC30A5—IgA glomerulonephritis	0.00216	0.00216	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC38A2—IgA glomerulonephritis	0.00216	0.00216	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—HMOX1—IgA glomerulonephritis	0.00215	0.00215	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—RHOA—IgA glomerulonephritis	0.0021	0.0021	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GNG12—IgA glomerulonephritis	0.00208	0.00208	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR1—IgA glomerulonephritis	0.00206	0.00206	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—CP—IgA glomerulonephritis	0.00194	0.00194	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—NMU—IgA glomerulonephritis	0.00193	0.00193	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C5AR1—IgA glomerulonephritis	0.00192	0.00192	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—GNG12—IgA glomerulonephritis	0.00188	0.00188	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (12/13) signalling events—RHOA—IgA glomerulonephritis	0.00185	0.00185	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—ADORA3—IgA glomerulonephritis	0.00178	0.00178	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—GPR65—IgA glomerulonephritis	0.00172	0.00172	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—MMP9—IgA glomerulonephritis	0.00167	0.00167	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ATP2B1—IgA glomerulonephritis	0.00164	0.00164	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—YWHAZ—IgA glomerulonephritis	0.00161	0.00161	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—TBL1XR1—IgA glomerulonephritis	0.00157	0.00157	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCR1—IgA glomerulonephritis	0.00157	0.00157	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR2—IgA glomerulonephritis	0.00155	0.00155	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC1A3—IgA glomerulonephritis	0.00146	0.00146	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—C5AR1—IgA glomerulonephritis	0.00146	0.00146	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ATP2B1—IgA glomerulonephritis	0.00145	0.00145	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ARHGAP11A—IgA glomerulonephritis	0.00141	0.00141	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ARHGAP22—IgA glomerulonephritis	0.00141	0.00141	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—TBL1XR1—IgA glomerulonephritis	0.00139	0.00139	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—ALB—IgA glomerulonephritis	0.00136	0.00136	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR2—IgA glomerulonephritis	0.00133	0.00133	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—FPR3—IgA glomerulonephritis	0.00132	0.00132	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—CP—IgA glomerulonephritis	0.0013	0.0013	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC1A3—IgA glomerulonephritis	0.0013	0.0013	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ECT2—IgA glomerulonephritis	0.00128	0.00128	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—GNG12—IgA glomerulonephritis	0.00126	0.00126	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—GNG12—IgA glomerulonephritis	0.00126	0.00126	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—FPR3—IgA glomerulonephritis	0.0012	0.0012	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—AGT—IgA glomerulonephritis	0.0012	0.0012	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ECT2—IgA glomerulonephritis	0.00116	0.00116	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—CP—IgA glomerulonephritis	0.00116	0.00116	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—HMOX1—IgA glomerulonephritis	0.00115	0.00115	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PSAP—IgA glomerulonephritis	0.00113	0.00113	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—GNG12—IgA glomerulonephritis	0.00112	0.00112	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—PTHLH—IgA glomerulonephritis	0.00111	0.00111	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—AMPK Signaling—PIK3CA—IgA glomerulonephritis	0.0011	0.0011	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—NMU—IgA glomerulonephritis	0.00109	0.00109	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—IgA glomerulonephritis	0.00107	0.00107	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—MAPK1—IgA glomerulonephritis	0.00104	0.00104	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (12/13) signalling events—PIK3CA—IgA glomerulonephritis	0.00103	0.00103	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—RGS4—IgA glomerulonephritis	0.00102	0.00102	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCR2—IgA glomerulonephritis	0.00101	0.00101	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADORA3—IgA glomerulonephritis	0.001	0.001	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—IgA glomerulonephritis	0.000999	0.000999	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—NMU—IgA glomerulonephritis	0.000988	0.000988	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—METAP2—IgA glomerulonephritis	0.000974	0.000974	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GPR65—IgA glomerulonephritis	0.00097	0.00097	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—RGS4—IgA glomerulonephritis	0.000929	0.000929	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—TGFB1—IgA glomerulonephritis	0.00092	0.00092	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—IgA glomerulonephritis	0.000917	0.000917	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADORA3—IgA glomerulonephritis	0.000912	0.000912	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCR1—IgA glomerulonephritis	0.000887	0.000887	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GPR65—IgA glomerulonephritis	0.000881	0.000881	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—IgA glomerulonephritis	0.000856	0.000856	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—IgA glomerulonephritis	0.000836	0.000836	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—C5AR1—IgA glomerulonephritis	0.000825	0.000825	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—TGFB1—IgA glomerulonephritis	0.000815	0.000815	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—IgA glomerulonephritis	0.000812	0.000812	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ATP6V1B2—IgA glomerulonephritis	0.000807	0.000807	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TMED2—IgA glomerulonephritis	0.000807	0.000807	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCR1—IgA glomerulonephritis	0.000805	0.000805	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—MAPK1—IgA glomerulonephritis	0.000799	0.000799	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—IgA glomerulonephritis	0.000795	0.000795	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—HMOX1—IgA glomerulonephritis	0.000776	0.000776	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—C5AR1—IgA glomerulonephritis	0.000749	0.000749	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GNG12—IgA glomerulonephritis	0.000712	0.000712	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FPR3—IgA glomerulonephritis	0.000711	0.000711	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ALB—IgA glomerulonephritis	0.000692	0.000692	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—HMOX1—IgA glomerulonephritis	0.000687	0.000687	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ECT2—IgA glomerulonephritis	0.000686	0.000686	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PSAP—IgA glomerulonephritis	0.000665	0.000665	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—IgA glomerulonephritis	0.000654	0.000654	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCR5—IgA glomerulonephritis	0.000652	0.000652	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GNG12—IgA glomerulonephritis	0.000646	0.000646	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADAM12—IgA glomerulonephritis	0.000645	0.000645	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—C3—IgA glomerulonephritis	0.000637	0.000637	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ABI1—IgA glomerulonephritis	0.000628	0.000628	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PTHLH—IgA glomerulonephritis	0.000625	0.000625	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—IgA glomerulonephritis	0.000621	0.000621	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CAB39—IgA glomerulonephritis	0.000612	0.000612	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—AGT—IgA glomerulonephritis	0.000605	0.000605	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NMU—IgA glomerulonephritis	0.000584	0.000584	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCNC—IgA glomerulonephritis	0.000584	0.000584	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCR2—IgA glomerulonephritis	0.000572	0.000572	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PTHLH—IgA glomerulonephritis	0.000567	0.000567	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—IgA glomerulonephritis	0.000561	0.000561	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RGS4—IgA glomerulonephritis	0.000549	0.000549	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADORA3—IgA glomerulonephritis	0.000539	0.000539	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GPR65—IgA glomerulonephritis	0.00052	0.00052	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCR2—IgA glomerulonephritis	0.000519	0.000519	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—IgA glomerulonephritis	0.000511	0.000511	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCL2—IgA glomerulonephritis	0.000498	0.000498	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—UBE2D3—IgA glomerulonephritis	0.000496	0.000496	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—PIK3CA—IgA glomerulonephritis	0.000496	0.000496	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RACGAP1—IgA glomerulonephritis	0.000489	0.000489	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—MAPK1—IgA glomerulonephritis	0.000476	0.000476	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCR1—IgA glomerulonephritis	0.000476	0.000476	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TBL1XR1—IgA glomerulonephritis	0.000476	0.000476	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ITCH—IgA glomerulonephritis	0.000476	0.000476	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ALB—IgA glomerulonephritis	0.000466	0.000466	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—VAV3—IgA glomerulonephritis	0.00045	0.00045	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—IgA glomerulonephritis	0.000443	0.000443	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—C5AR1—IgA glomerulonephritis	0.000442	0.000442	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—YES1—IgA glomerulonephritis	0.00042	0.00042	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ALB—IgA glomerulonephritis	0.000413	0.000413	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—VAV3—IgA glomerulonephritis	0.000408	0.000408	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CHEK1—IgA glomerulonephritis	0.000401	0.000401	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CYBB—IgA glomerulonephritis	0.000394	0.000394	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GNG12—IgA glomerulonephritis	0.000382	0.000382	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCR5—IgA glomerulonephritis	0.000368	0.000368	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NCF2—IgA glomerulonephritis	0.000361	0.000361	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—C3—IgA glomerulonephritis	0.00036	0.00036	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RASA1—IgA glomerulonephritis	0.000351	0.000351	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EREG—IgA glomerulonephritis	0.000343	0.000343	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AGT—IgA glomerulonephritis	0.000342	0.000342	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PTHLH—IgA glomerulonephritis	0.000335	0.000335	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCR5—IgA glomerulonephritis	0.000334	0.000334	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—C3—IgA glomerulonephritis	0.000327	0.000327	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PSME3—IgA glomerulonephritis	0.000317	0.000317	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AGT—IgA glomerulonephritis	0.000311	0.000311	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCR2—IgA glomerulonephritis	0.000307	0.000307	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CHUK—IgA glomerulonephritis	0.000293	0.000293	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MAP3K7—IgA glomerulonephritis	0.00026	0.00026	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—H2AFZ—IgA glomerulonephritis	0.000258	0.000258	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADAM10—IgA glomerulonephritis	0.000257	0.000257	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCL2—IgA glomerulonephritis	0.000256	0.000256	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—RHOA—IgA glomerulonephritis	0.000254	0.000254	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—VAV3—IgA glomerulonephritis	0.000241	0.000241	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—RHOA—IgA glomerulonephritis	0.00023	0.00023	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—YWHAZ—IgA glomerulonephritis	0.000205	0.000205	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCR5—IgA glomerulonephritis	0.000198	0.000198	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—C3—IgA glomerulonephritis	0.000193	0.000193	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AGT—IgA glomerulonephritis	0.000183	0.000183	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CD80—IgA glomerulonephritis	0.000163	0.000163	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—NRAS—IgA glomerulonephritis	0.000162	0.000162	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL2—IgA glomerulonephritis	0.000151	0.000151	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—MAPK1—IgA glomerulonephritis	0.000148	0.000148	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PIK3CA—IgA glomerulonephritis	0.000141	0.000141	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SERPINE1—IgA glomerulonephritis	0.000141	0.000141	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RHOA—IgA glomerulonephritis	0.000136	0.000136	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PIK3CA—IgA glomerulonephritis	0.000128	0.000128	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MMP9—IgA glomerulonephritis	0.000108	0.000108	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PTEN—IgA glomerulonephritis	0.000107	0.000107	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NRAS—IgA glomerulonephritis	9.58e-05	9.58e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TGFB1—IgA glomerulonephritis	8.9e-05	8.9e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MAPK1—IgA glomerulonephritis	8.73e-05	8.73e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PIK3CA—IgA glomerulonephritis	7.58e-05	7.58e-05	CbGpPWpGaD
